PATENT CLAIM ANALYSIS

Application Number: 16119027
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "400000"]

Abstract:
Provided are methods relating to compositions that include a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.

Claim (Index 10):
The method of  claim 1 , wherein the pyrimidine analogue is capecitabine.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.05556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15312139', '14885174', '14955469', '15069208', '15723981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6925928725170066
- 35 USC 102 Novelty (BERT): 0.4992292797627679
- Combined Prediction Score: 0.6732565132415829
- Mean Citation Score: 200.970564
- Max Citation Score: 204.61128
- Similarity Product: 132.2713853545475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test